Icon

MAKENA AUTO-INJECTOR - (275 mg/1.1 mL solution)

Hydroxyprogesterone Caproate COVIS Pharma
275 mg/1.1 mL solution
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
None None
Makena is a progestin indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
Yes
***** (*********) ******** ***** ***** *** **** ** ****** ** ******* '*** & '*** (***- *** *, ****) *** *** ****. ** *** **, **** *** ****** * *********, *********** *** ******** ** ****** *** *********** *** **** ** ****** *** *** ******** **** *** ** ******.
MAKENA AUTO-INJECTOR Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10
********* ******* ******* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
********* *** \ ********* *** **, **** ******* **** ** ****** *** ********
  1. *** **, **** : * **** ** *** *****.
  2. *** **, **** : ***** (*********) ******** ***** ***** *** **** ** ****** ** ******* '*** & '*** (***- *** *, ****).
  3. *** **, **** : ***** (*********) *** ********* *** ******* '*** & '***.
  4. *** *, **** : ***** (*********) *** ********* *** ******* '*** & '***.
  5. *** *, **** : ***** ****** **** ***** (*********) **** ************ ** ***** ****** ****** '*** (*** **, ****)
  6. *** **, **** : ***** ****** **** ***** (*********) **** ************ ** ***** ****** ****** '*** (*** **, ****)
  7. *** **, **** : ***** ****** *** ***** ******* ******** **********. ** ****** ** *** * **********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.